Near Missed Case of Occupational Pleural Malignant Mesothelioma, a Case Report and Latest Therapeutic Options

被引:5
作者
Handra, Claudia-Mariana [1 ]
Chirila, Marinela [2 ]
Smarandescu, Raluca-Andreea [1 ]
Ghita, Isabel [3 ]
机构
[1] Carol Davila Univ Med & Pharm, Occupat Hlth Dept, Bucharest 050474, Romania
[2] Titu Maiorescu Univ, Fac Pharm, Bucharest 040441, Romania
[3] Carol Davila Univ Med & Pharm, Pharm & Pharmacol Dept, Bucharest 050474, Romania
关键词
pleural malignant mesothelioma; asbestos; occupational exposure; DIAGNOSIS; EPIDEMIOLOGY;
D O I
10.3390/ijerph192214763
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Asbestos use started to be gradually banned in Europe from 1991 onwards, and there are currently strict occupational exposure limits for asbestos. However, malignant mesothelioma has a long latency time (in some cases up to 50-60 years), so the risks related to asbestos exposure should not be forgotten. Considering the increased risk of lung cancer following the inhalation of asbestos fibers, lifetime health monitoring should be considered in people occupationally exposed to asbestos, with an emphasis on the respiratory system. An assessment of their occupational history should be performed rigorously, especially in the areas with a history of asbestos production/use, as this is a key element for an early diagnosis and appropriate treatment. This case report presents a near-missed case of occupational pleural malignant mesothelioma. The latency time between the first asbestos exposure and the diagnosis of occupational pleural malignant mesothelioma was 49 years. The accurate diagnosis was made two years after the first symptoms appeared.
引用
收藏
页数:8
相关论文
共 25 条
[11]   Management of Advanced Pleural Mesothelioma-At the Crossroads [J].
Nowak, Anna K. ;
Jackson, Alannah ;
Sidhu, Calvin .
JCO ONCOLOGY PRACTICE, 2022, 18 (02) :116-+
[12]   A randomised trial in malignant mesothelioma (M) of early (E) versus delayed (D) chemotherapy in symptomatically stable patients: the MED trial [J].
O'Brien, MER ;
Watkins, D ;
Ryan, C ;
Priest, K ;
Corbishley, C ;
Norton, A ;
Ashley, S ;
Rowell, N ;
Sayer, R .
ANNALS OF ONCOLOGY, 2006, 17 (02) :270-275
[13]  
Otelea MR, 2019, REV CHIM-BUCHAREST, V70, P2155
[14]   Pleural Plaques and the Risk of Pleural Mesothelioma [J].
Pairon, Jean-Claude ;
Laurent, Francois ;
Rinaldo, Mickael ;
Clin, Benedicte ;
Andujar, Pascal ;
Ameille, Jacques ;
Brochard, Patrick ;
Chammings, Soizick ;
Ferretti, Gilbert ;
Galateau-Salle, Francoise ;
Gislard, Antoine ;
Letourneux, Marc ;
Luc, Amandine ;
Schorle, Evelyne ;
Paris, Christophe .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (04) :293-301
[15]   Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].
Popat, S. ;
Baas, P. ;
Faivre-Finn, C. ;
Girard, N. ;
Nicholson, A. G. ;
Nowak, A. K. ;
Opitz, I. ;
Scherpereel, A. ;
Reck, M. .
ANNALS OF ONCOLOGY, 2022, 33 (02) :129-142
[16]  
Rascu A, 2016, ROM J MORPHOL EMBRYO, V57, P1171
[17]   Extrapleural pneumonectomy for early stage malignant pleural mesothelioma: A harmful procedure [J].
Rena, Ottavio ;
Casadio, Caterina .
LUNG CANCER, 2012, 77 (01) :151-155
[18]   New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma [J].
Rossini, Marika ;
Rizzo, Paola ;
Bononi, Ilaria ;
Clementz, Anthony ;
Ferrari, Roberto ;
Martini, Fernanda ;
Tognon, Mauro G. .
FRONTIERS IN ONCOLOGY, 2018, 8
[19]   Malignant Pleural Mesothelioma, Biphasic Type: An Unusual and Insidious Case of Rapidly Progressive Small Blue Cell Tumor [J].
Salazar, Carlos ;
Kanter, Nelson ;
Abboud, Amer .
CUREUS, 2018, 10 (06)
[20]   Novel and Future Treatment Options in Mesothelioma: A Systematic Review [J].
Strbac, Danijela ;
Dolzan, Vita .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (04)